Clinical trials recruiting for PARKINSON DISEASE (Disorder)

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Clinical Study to Evaluate the Safety of MF1, a New Treatment for Parkinson's Disease-related Disorders (MF1 Study)
  NCT07666022 · Phase: Phase 1 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
  NCT07804615 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 30 locations
• Adapting rHIRE and Sleep Monitoring in Parkinson's Disease
  NCT07498296 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Brief Title: Aerobic Training on Cerebrovascular Function, Cognition and Gait in Parkinson's Disease
  NCT07478146 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Characterization and Validation of the Short Physical Performance Battery in Individuals Diagnosed With Parkinson's Disease
  NCT07780461 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Cognitive Recovery Via Sensor-based Robotic Upper Limb Rehabilitation in Neurological Disorders
  NCT07384143 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
  NCT07217054 · Phase: Not specified · Ages: 40 Years to 99 Years · Sex: All (male and female) · 1 location
• Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
  NCT07204652 · Phase: Not specified · Ages: 40 Years to 99 Years · Sex: All (male and female) · 1 location
• Effect of Vitamin D3 on Brain Waves in Male Parkinson's Patients With Low Vitamin D: A qEEG Study
  NCT07096336 · Phase: Not applicable (e.g. observational or device study) · Ages: 51 Years to 70 Years · Sex: Male · 1 location
• Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease
  NCT07554833 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 90 Years · Sex: All (male and female) · 1 location
• Effects of Motor Imagery Training
  NCT07193355 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• Effects of Tai Chi Therapy Versus Qi-Gong in Stage-I Parkinson's Patients.
  NCT07662837 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 65 Years · Sex: All (male and female) · 2 locations
• Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease
  NCT07226284 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 76 Years · Sex: All (male and female) · 1 location
• Feasibility of a Community-Based Multimodal Exercise Programme in Parkinson's Disease
  NCT07618728 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• GBPDC: Gut-Brain in PD Consortium Master Protocol
  NCT07567794 · Phase: Not specified · Ages: 21 Years to 80 Years · Sex: All (male and female) · 7 locations
• Integrated Digital and Neurogenic Exosome Biomarkers for Early Diagnosis of Parkinson's Disease: Development and Application
  NCT07679256 · Phase: Not specified · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
  NCT07151378 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 7 locations
• Italian Translation and Validation of the GIDS-PD Scale for Parkinson's Disease
  NCT07316751 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Mediterranean Diet Effects on Parkinson's Disease
  NCT06705517 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 85 Years · Sex: All (male and female) · 1 location
• Mental Imagery on Upper Extremity Skills
  NCT07193303 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)
  NCT07360977 · Phase: Not applicable (e.g. observational or device study) · Ages: 1 Year to 75 Years · Sex: All (male and female) · 1 location
• Neural Correlates of Motor and Psychiatric Fluctuations in Parkinson's Disease
  NCT07404241 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Optimizing Adaptive DBS for Parkinson's Disease
  NCT07798271 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Physical Activity in Persons With Parkinson's Disease
  NCT07585409 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease.
  NCT07467460 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Predictors of Clinical Outcomes of Deep Brain Stimulation in Parkinson's Disease
  NCT07376278 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease
  NCT05568498 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• Protocol of the Packer Managing Fatigue Program Versus Standard Information to Improve Energy Conservation Self-Efficacy in Parkinson's Disease
  NCT07094269 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Remotely Supervised Home-based Transcranial Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease
  NCT07518290 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: All (male and female) · 2 locations
• SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
  NCT07422675 · Phase: Phase 1 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 6 locations
• Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
  NCT07461220 · Phase: Phase 1, Phase 2 · Ages: 50 Years to 90 Years · Sex: All (male and female) · 14 locations
• Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor Fluctuations
  NCT07761936 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Short and Long-term Responses of PD Symptoms to Earstim
  NCT07400731 · Phase: Not applicable (e.g. observational or device study) · Ages: 44 Years and older · Sex: All (male and female) · 2 locations
• The Effect of Long-term Daily Stimulation of the Brain With Pulsed Electromagnetic Fields on Parkinsons Disease
  NCT07306104 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• The Effect of an Auditory Rhythmic Cue on the Frequency of Rolling in Patients with Dysphagia and Parkinson's Disease
  NCT06695455 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
  NCT07786116 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · 2 locations
• Understanding How Movements Are Transferred From Task to Task in Parkinson's Disease
  NCT07351032 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
  NCT07557706 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms
  NCT07182058 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Whole-Body Photobiomodulation for Motor and Cognitive Changes in Parkinson's Disease
  NCT07271927 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for PARKINSON DISEASE (Disorder) often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for PARKINSON DISEASE (Disorder) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.